New Shot-in-the-Arm cancer drug shows promise in Real-World study

This study looks at how well a new cancer drug called envafolimab works in everyday medical practice. Envafolimab is given as a simple shot under the skin, not through an IV, making treatment faster and easier. The study will include about 120 adults with advanced solid tumors who have not responded to standard treatments. Researchers will track tumor control, survival, and side effects to see how the drug performs outside of early clinical trials.